56 filings
8-K
FULC
Fulcrum Therapeutics Inc
27 Feb 24
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:01am
8-K
FULC
Fulcrum Therapeutics Inc
7 Nov 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:02am
8-K
FULC
Fulcrum Therapeutics Inc
2 Oct 23
Departure of Directors or Certain Officers
4:01pm
8-K
FULC
Fulcrum Therapeutics Inc
22 Aug 23
Regulation FD Disclosure
7:01am
8-K
FULC
Fulcrum Therapeutics Inc
3 Aug 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:05am
8-K
ve3q7keduy
10 Jul 23
Entry into a Material Definitive Agreement
5:06pm
8-K
r7p5bu16
9 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
mh12tah2abp3z o5i
15 May 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:06am
8-K
bqnq3
5 Apr 23
Departure of Directors or Certain Officers
8:13am
8-K
ag0k9l kcqjgy
9 Mar 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:14am
8-K
4sa5y7m sulii
18 Jan 23
Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
5:12pm
8-K
5ytm1dt55i7
17 Jan 23
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
4:53pm
8-K
valdqvx3py7wkt6di
4 Jan 23
Fulcrum Therapeutics Provides Business Update and 2023 Outlook
7:12am
8-K
10pp 9ndgfqwra
8 Nov 22
Fulcrum Therapeutics Announces Recent Business Highlights
7:36am
8-K
wi530oztwd gfud94ec
19 Oct 22
Departure of Directors or Certain Officers
4:06pm
8-K
o2bmj25c
23 Aug 22
Other Events
4:58pm
8-K
evvk 4xrpe
16 Aug 22
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
5:59pm
8-K
ytmyj7g6pl2
11 Aug 22
Departure of Directors or Certain Officers
7:05am
8-K
jitj45pnibzy z9
11 Aug 22
Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results
7:02am
8-K
jxk87q
11 Jul 22
Departure of Directors or Certain Officers
5:09pm